These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 9714208)

  • 1. Overproduction of SM28GST in a baculovirus expression vector and its use to evaluate the in vivo immune responses of mice vaccinated against Schistosoma mansoni with naked DNA encoding the SM28GST gene.
    Kayes SG; Shaneyfelt RC; Monteiro C; O'Brien JJ
    J Parasitol; 1998 Aug; 84(4):764-70. PubMed ID: 9714208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutralizing antibody responses elicited in mice immunized with recombinant bacillus Calmette-Guérin producing the Schistosoma mansoni glutathione S-transferase.
    Kremer L; Riveau G; Baulard A; Capron A; Locht C
    J Immunol; 1996 Jun; 156(11):4309-17. PubMed ID: 8666802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intradermal immunization of rats with plasmid DNA encoding Schistosoma mansoni 28 kDa glutathione S-transferase.
    Dupré L; Poulain-Godefroy O; Ban E; Ivanoff N; Mekranfar M; Schacht AM; Capron A; Riveau G
    Parasite Immunol; 1997 Nov; 19(11):505-13. PubMed ID: 9427997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Vaccination of mice with recombinant nucleic acid vaccine encoding the integral membrane protein Sj23 and cytokine IL-12 elicits specific immune responses against schistosoma japonica].
    Gan Y; Shi YE; Bu LY; Ning CX; Zhu HG
    Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(3):193-8. PubMed ID: 15854467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of schistosomiasis pathology by combination of Sm28GST DNA immunization and praziquantel treatment.
    Dupré ; Herv M; Schacht AM; Capron A; Riveau G
    J Infect Dis; 1999 Aug; 180(2):454-63. PubMed ID: 10395862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fasciola gigantica and Schistosoma mansoni: vaccine potential of recombinant glutathione S-transferase (rFgGST26) against infections in mice.
    Preyavichyapugdee N; Sahaphong S; Riengrojpitak S; Grams R; Viyanant V; Sobhon P
    Exp Parasitol; 2008 Jun; 119(2):229-37. PubMed ID: 18329021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Schistosoma mansoni hexokinase: cDNA cloning and immunogenicity studies.
    Shoemaker CB; Reynolds SR; Wei G; Tielens AG; Harn DA
    Exp Parasitol; 1995 Feb; 80(1):36-45. PubMed ID: 7821409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasal administration of a Schistosoma mansoni glutathione S-transferase-cholera toxoid conjugate vaccine evokes antiparasitic and antipathological immunity in mice.
    Sun JB; Mielcarek N; Lakew M; Grzych JM; Capron A; Holmgren J; Czerkinsky C
    J Immunol; 1999 Jul; 163(2):1045-52. PubMed ID: 10395703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular cloning, expression and vaccination of a novel gene Sj-MA of Schistosoma japonicum.
    Chen YX; Yi XY; Zeng XF; Yuan SS; Zhang SK; McReynolds L
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Nov; 35(11):981-5. PubMed ID: 14614534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Schistosoma mansoni irradiated cercariae and Sm23 DNA vaccines.
    Ganley-Leal LM; Guarner J; Todd CW; Da'Dara AA; Freeman GL; Boyer AE; Harn DA; Secor WE
    Parasite Immunol; 2005 Sep; 27(9):341-9. PubMed ID: 16149992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Candidate vaccine antigens that stimulate the cellular immune response of mice vaccinated with irradiated cercariae of Schistosoma mansoni.
    Richter D; Reynolds SR; Harn DA
    J Immunol; 1993 Jul; 151(1):256-65. PubMed ID: 8326127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A recombinant protein from Schistosoma mansoni useful for the detection of S. mansoni and Schistosoma haematobium antibodies.
    Hancock K; Mohamed YB; Haichou X; Noh J; Dotson EM; Tsang VC
    J Parasitol; 1997 Aug; 83(4):612-8. PubMed ID: 9267400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunization with SmIg, a novel tegument protein from Schistosoma mansoni, fails to induce protection in mice but reduces liver pathology.
    Pinho JM; Cardoso FC; Lopes DO; Pinheiro CS; Caliari MV; Oliveira FM; Leite LC; Oliveira SC
    Parasitology; 2010 Jun; 137(7):1079-88. PubMed ID: 19835649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Construction of a novel Schistosoma japonicum DNA vaccine pBK-Sj14-3-3 and studies on its immunoprotection in mice].
    Li DF; Chen YS; Zu Y; Shen JL
    Zhonghua Yu Fang Yi Xue Za Zhi; 2004 May; 38(3):193-5. PubMed ID: 15182491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Saposin-like proteins are expressed in the gastrodermis of Schistosoma mansoni and are immunogenic in natural infections.
    Don TA; Bethony JM; Loukas A
    Int J Infect Dis; 2008 Nov; 12(6):e39-47. PubMed ID: 18571965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune responses against Schistosoma japonicum after vaccinating mice with a multivalent DNA vaccine encoding integrated membrane protein Sj23 and cytokine interleukin-12.
    Gan Y; Shi YE; Bu LY; Zhu XH; Ning CX; Zhu HG
    Chin Med J (Engl); 2004 Dec; 117(12):1842-6. PubMed ID: 15603716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunostimulatory effect of IL-18-encoding plasmid in DNA vaccination against murine Schistosoma mansoni infection.
    Dupré L; Kremer L; Wolowczuk I; Riveau G; Capron A; Locht C
    Vaccine; 2001 Jan; 19(11-12):1373-80. PubMed ID: 11163659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies elicited by naked DNA vaccination against the complementary-determining region 3 hypervariable region of immunoglobulin heavy chain idiotypic determinants of B-lymphoproliferative disorders specifically react with patients' tumor cells.
    Rinaldi M; Ria F; Parrella P; Signori E; Serra A; Ciafrè SA; Vespignani I; Lazzari M; Farace MG; Saglio G; Fazio VM
    Cancer Res; 2001 Feb; 61(4):1555-62. PubMed ID: 11245465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on the development of DNA vaccine against Cysticercus cellulosae infection and its efficacy.
    Cai X; Chai Z; Jing Z; Wang P; Luo X; Chen J; Dou Y; Feng S; Su C; Jin J
    Southeast Asian J Trop Med Public Health; 2001; 32 Suppl 2():105-10. PubMed ID: 12041570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunization with Schistosoma mansoni 22.6 kDa antigen induces partial protection against experimental infection in a recombinant protein form but not as DNA vaccine.
    Pacífico LG; Fonseca CT; Chiari L; Oliveira SC
    Immunobiology; 2006; 211(1-2):97-104. PubMed ID: 16446174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.